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AbstrAct
Objective Medical billing data are an attractive source 
of secondary analysis because of their ease of use and 
potential to answer population- health questions with 
statistical power. Although these datasets have known 
susceptibilities to biases, the degree to which they 
can distort the assessment of quality measures such 
as colorectal cancer screening rates are not widely 
appreciated, nor are their causes and possible solutions.
Methods Using a billing code database derived from 
our institution’s electronic health records, we estimated 
the colorectal cancer screening rate of average- risk 
patients aged 50–74 years seen in primary care or 
gastroenterology clinic in 2016–2017. 200 records (150 
unscreened, 50 screened) were sampled to quantify the 
accuracy against manual review.
Results Out of 4611 patients, an analysis of billing 
data suggested a 61% screening rate, an estimate that 
matches the estimate by the Centers for Disease Control. 
Manual review revealed a positive predictive value of 
96% (86%–100%), negative predictive value of 21% 
(15%–29%) and a corrected screening rate of 85% (81%–
90%). Most false negatives occurred due to examinations 
performed outside the scope of the database—both within 
and outside of our institution—but 21% of false negatives 
fell within the database’s scope. False positives occurred 
due to incomplete examinations and inadequate bowel 
preparation. Reasons for screening failure include ordered 
but incomplete examinations (48%), lack of or incorrect 
documentation by primary care (29%) including incorrect 
screening intervals (13%) and patients declining screening 
(13%).
Conclusions Billing databases are prone to substantial 
bias that may go undetected even in the presence of 
confirmatory external estimates. Caution is recommended 
when performing population- level inference from these 
data. We propose several solutions to improve the use of 
these data for the assessment of healthcare quality.
InTroducTIon
Colorectal cancer (CRC) screening is a high 
priority for public health in the USA and 
abroad. Although CRC remains the second 
leading cause of cancer- related death in the 
USA,1 screening via modalities such as colo-
noscopy have the potential to reduce the 
mortality rate by 60% or more.2 Despite its 
potential for such impact, screening uptake 
as estimated by the Centers for Disease 
Control (CDC) has remained stagnant at 60% 
for at least a decade.3 4 These findings have 
prompted multiple calls for action such as the 
80% by 2018 campaign led by the National 
Colorectal Cancer Roundtable.
The traditional benchmark for measuring 
CRC screening rates in the USA has been the 
National Health Interview Survey—an annual 
survey of the civilian and non- institutionalised 
population. Although these data are consid-
ered the gold standard, they suffer from 
a number of shortcomings including low 
participation rates (55%),4 recall bias, lack 
of confirmation with the medical record, 
uneven health literacy and social desirability 
bias.5
An alternative source that avoids many of 
the aforementioned pitfalls is administrative 
healthcare data (see online supplementary 
table 1 for definition of all healthcare data- 
related terms as used in this article, adapted 
with permission from Rudrapatna and Butte6). 
Although these data were originally collected 
to support operations and financial objec-
tives, they could potentially be useful for many 
other purposes: tracking the effectiveness of 
screening outreach measures, providing clin-
ical decision support and rewarding providers 
and health systems for value- based care.7
However, precisely because these data 
were originally assembled for other reasons, 
they are prone to measurement bias.8 More 
concerning, many large structured datasets 
such as those derived from medical claims 
can be difficult to validate, in part due to 
disconnection from the underlying medical 
context. Therefore, even though transparent 
and repeated benchmarking is a critical step 
for any valid data repurposing endeavour, 
this is rarely done.
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Figure 1 Cohort selection schematic.
Although it can be difficult to benchmark the accuracy 
of claims data from payor databases, billing data derived 
from the electronic health records (EHR) may represent 
a good proxy for two reasons: 1) much of claims data are 
derived from bills generated by EHR software over the 
course of clinical operations and 2) algorithms based 
on these data may be validated against the full clinical 
context captured in the EHR.
In this analytical study, we attempt to answer the ques-
tion: how accurately do medical billing data capture the 
CRC screening rates within a healthcare system? Here, we 
perform an informatics- based estimation of the period 
prevalent screening rate using billing data derived from 
the EHR. We then review a random sample of charts in 
order to identify the reasons for algorithmic misclassifi-
cation and missed screening. We conclude by proposing 
strategies to enhance future clinical informatics efforts 
and improve the primary prevention of CRC.
MeThods
clinical data
EHR data were extracted from the University of Cali-
fornia, San Francisco (UCSF) Epic system using Clarity 
and Caboodle tools.9 To perform analysis on a dataset 
closely resembling typical payor claims databases in terms 
of constituent elements, we extracted the following struc-
tured fields: age, gender, ‘alive’ status, race, primary 
language, ethnicity, insurance, department, diagnosis 
code, procedure code, and encounter date.
Prior to being used for this study, the data was de- iden-
tified to comply with the US Department of Health and 
Human Services ‘Safe Harbor’ guidance. Temporal 
imprecision was introduced into the dataset via a random 
negative date offset (0–364 days).
study population
We included patients aged 50–74 years who had at least 
two primary care visits, two gastroenterology clinic visits 
or one of each between January 2016 and December 
2017 (figure 1). This criteria was used in order to exclude 
patients who had sought care for an isolated ‘sick visit’, 
and specifically identify patients with a clearly established 
primary care or gastroenterology relationship. These 
patients would be expected to be considered for colon 
cancer screening during the office visit. We included 
patients with only gastroenterology visits because may 
patients receive regular gastroenterology care at our insti-
tution, and these gastroenterologists counsel and refer 
many patients for CRC screening. Most of the patients in 
our cohort were included on the basis of being empan-
elled in primary care rather than gastroenterology care.
We excluded charts bearing the following International 
Classification of Disease, Tenth Revision, Clinical Modi-
fication (ICD-10- CM) codes reflecting an elevated risk 
of CRC: family history of colon polyps (Z83.71, Z83.79), 
family history colon cancer (Z80.0, Z80.9), personal 
history of colon polyps (Z86.010, K63.5, D12, K63.5), 
personal history of colon cancer (C18- C21), hereditary 
non- polyposis CRC/Lynch syndrome (Z15.09 Z14.8, 
Z80.0, Z84.81), familial adenomatous polyposis (D12.6, 
Z14.8), juvenile polyposis syndrome (D12.6), Peutz- 
Jehgers syndrome (Q85.8, L81) and inflammatory bowel 
disease (K50, K51). We reviewed records corresponding 
to code Z98.89; patients who were annotated as having 
either a history of prior lower endoscopy or colectomy 
and lacked an order for a screening examination were 
excluded.
classification algorithm
We identified charts with a prior history of lower endos-
copy using Current Procedural Terminology (CPT) codes 
(see online supplementary methods). Additionally, we 
used regular expression- based string matching to identify 
billed- for procedures corresponding to colonography- 
protocoled CT (CT colonography), double contrast 
barium enema and faecal immunochemical test. Capsule 
colonoscopies, guaiac- based stool testing and faecal DNA 
tests are not performed at our facility.
We used the following schedule to determine the pres-
ence or absence of a qualifying screening examination: 
colonoscopy within the prior 10 years, sigmoidoscopy 
within the prior 5 years, faecal immunochemical test 
(FIT) in 2016, CT colonography within the last 5 years, 
double contrast barium enema within the last 5 years. 
Patients were classified as screened if they had been 
screened according to this schedule as of March 2018.
database querying and analysis
All queries required several rounds of iterative refine-
ment done in close collaboration between the clinical 
and bioinformatics teams. Identification and verifica-
tion of CPT codes were performed in close consultation 
with gastroenterology billing specialists. ICD-10 codes 
were selected by manual review. Encounter names corre-
sponding to primary care visits were identified by discus-
sion with primary care physicians. Data extraction was 
performed using MySQL (V.5.6.10). Further refinement 
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Table 1 Demographics of primary care cohort at average 
risk for colorectal cancer at the University of California, San 
Francisco
Average risk
Primary care cohort
N (%) 4611
Age (years; mean±SD) 62±7
Sex N (%)   
  Male 1877 (41)
  Female 2734 (59)
Ethnicity N (%)   
  Hispanic or Latino 415 (9)
  Non- Hispanic or Latino 4076 (88)
Race N (%)   
  Asian 1278 (28)
  Black or African- American 524 (11)
  White or Caucasian 1949 (42)
Preferred language N (%)   
  English 4015 (87)
  Spanish 70 (2)
  Chinese—Cantonese 176 (4)
  Russian 19 (0)
  Chinese—Mandarin 84 (2)
Other, unknown and unspecified values were excluded.
and analysis was performed in the R programming envi-
ronment10 (V.3.4.1) using the RMySQL11 and  data. table12 
packages. Agresti- Coull binomial CIs13 were calculated 
for all estimates derived from random samples. Coverage 
probabilities of the 95% CI for prevalent screening rates 
were confirmed via Monte- Carlo simulation using 10 000 
replicates.
Manual chart review
After Institutional Review Board approval to proceed, 
we performed a stratified random sample of charts (50 
classified positive, 150 classified negative). This ratio of 
charts was intentionally weighted towards negative charts 
because we anticipated a higher false- negative classifi-
cation rate; as such, reviewing more negative charts was 
anticipated to be more informative. Two hundred charts 
were selected in total in order to achieve a reasonable 
balance of statistical precision with the effort required 
for chart review. A formal power calculation was not 
performed as this study was intended as an estimation 
study rather than one intending to test prespecified statis-
tical hypotheses.
Chart annotation criteria were serially developed and 
agreed on by all reviewers after each completing a test 
set of 10 charts independent of the above set. Charts 
were annotated by the reasons for screening or the lack 
thereof where appropriate (see online supplementary 
methods). Clinician documentation of a history of prior 
screening outside the institution was counted as evidence 
of screening. Charts were each independently reviewed 
and annotated by one internist and one gastroenterolo-
gist each, with all disagreements discussed and resolved. 
In scenarios where screening appeared to have not been 
performed due to a misunderstanding of the proper 
screening or surveillance interval, direct communication 
was made with the primary care provider.
Patient and public involvement statement
There were no funds or time allocated for patient and 
public involvement (PPI) for this retrospective chart 
review, so we were unable to involve patients. However, 
this study was approved by a review board that includes 
PPI.
resulTs
The population of patients aged 50–74 years with EHR 
data at our institution consisted of 291 420 patients, 
nearly a third of the total database population (figure 1 
and table 1). Within this cohort, we identified a subcohort 
of 4611 average risk patients empanelled in the primary 
care or gastroenterology clinics in the 2016–2017 period. 
Ninety- nine per cent of these patients met the inclusion 
criteria on the basis of primary care visits within the study 
period. Nearly 60% of the cohort was female with an 
average age of 62 years. The racial makeup of this cohort 
was 42% white, 28% Asian and 11% black. Eighty- eight 
per cent were of non- Hispanic or Latino ethnicity, and 
87% declared a primary language of English. Insurance 
coverage was collected but 95% of this information was 
missing.
We classified these patients by screened status based on 
the presence of antecedent procedure codes and calcu-
lated a screening rate of 61%.
We then performed manual review of 150 medical 
records lacking evidence of timely screening in the struc-
tured database (table 2). Thirty- one patients were correctly 
classified as unscreened, corresponding to a negative 
predictive value of 21%. Most of these patients had exam-
inations that were ordered but not completed, lacked 
documentation for unscreened status or were incorrectly 
documented by the responsible physician (eg, misunder-
standing of the screening interval). One hundred and 
four patients (69%, 95% CI 62% to 76%) had positive 
evidence of screening on manual review. Half of these 
underwent screening outside of our institution and 28% 
underwent screening prior to the implementation of the 
Epic EHR in June 2012. The remaining 22 false- negative 
records (21%) were associated with screening examina-
tions otherwise expected to occur within the theoretical 
scope of the database. Some of these errors were related 
to screening examinations performed around the time of 
database creation (March 2018) or Epic software instal-
lation (June 2012). The reasons identified for other 
errors were multifactorial but include errors of database 
creation and structure and at the level of querying. Lastly, 
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Table 2 Reasons for true and false classifications identified 
by manual chart review
Reasons for true negative 
classification
n=31, 21% (15% to 28%)
Examinations ordered but not 
completed
15, 48% (32% to 65%)
  Colonoscopy ordered but not 
completed
8
  Faecal immunochemical test 
ordered but not completed
6
  CT colonography ordered but 
not completed
1
Lack of documentation or incorrect 
documentation
9, 29% (16% to 47%)
Declined screening 4, 13% (5% to 29%)
Insufficient time to discuss 3, 10% (3% to 26%)
Reasons for false- negative 
misclassification
n=104, 69% (62% to 76%)
Screening outside of UCSF 53, 51% (41% to 60%)
Screening prior to Epic EHR 
implementation
29, 28% (20% to 37%)
Database and query errors 22, 21% (14% to 30%)
Misclassified as eligible for 
screening
n=15, 10% (6% to 16%)
Poor life expectancy, or risks 
outweighing benefits
8, 53% (30% to 75%)
Above risk (personal or family 
history of polyps)
6, 40% (20% to 64%)
Not primary care empanelled 1, 7% (0% to 32%)
Reasons for false- positive 
misclassification
n=2, 4% (0% to 14%))
Ordered but incomplete faecal 
immunochemical test
1, 50% (9% to 91%)
Performed colonoscopy revealed 
inadequate bowel preparation
1, 50% (9% to 91%)
The second column lists the number of charts and associated 
percentage of the group with 95% CIs.
EHR, electronic health records; UCSF, University of California, 
San Francisco.
15 patients (10%) were not actually eligible for screening, 
primarily due to the risks outweighing the benefits or 
otherwise being categorised as above- average risk.
Lastly, manual review of 50 records suggested to be 
up- to- date with screening indicated a positive predic-
tive value of 96% (95% CI 86% to 100%) (table 2). Two 
patients (4%) were unscreened—one ordered but incom-
plete FIT and one with a prior colonoscopy but inade-
quate bowel preparation.
Using the aforementioned positive and negative predic-
tive values, we calculated a corrected period prevalent 
screening rate of 85% (81%–90%). The most common 
screening modality used was colonoscopy. Other notable 
global findings include four charts with incorrectly docu-
mented surveillance intervals. For example, one chart 
with a negative FIT in 2014 was incorrectly flagged for 
follow- up screening in 2024. We identified one patient 
who screened positive by FIT and was referred for colo-
noscopy, but the referral expired. We noted occasional 
discrepancies between surveillance intervals proposed by 
the gastroenterologist and primary care physician (eg, 
5- year vs 10- year follow- up).
dIscussIon
Medical billing databases available from either healthcare 
payors or from the EHR (as used in this study) are attrac-
tive sources of secondary data analysis for research, oper-
ations and quality improvement for a variety of reasons. 
They are increasingly accessible and relatively easy to 
query using common database languages. They are far 
easier to use for analysis compared with free- text data 
within the EHR such as in clinical notes. Because these 
databases tend to cover large patient cohorts (1.2 million 
in our EHR database, tens to hundreds of millions in 
many commercially available databases derived from 
claims data), they are accompanied by considerable statis-
tical power and the potential for population- level infer-
ence.
A shortcoming of these data is that they were not 
collected specifically for research purposes, and thus are 
intrinsically prone to measurement bias. This is especially 
a problem for datasets (such as those from healthcare 
payors) that cannot be validated against a ground source 
of truth due to de- identification and de- linkage from 
the EHR. Although a common practice in the field of 
secondary data analysis involves the ‘external validation’ 
of study results against that obtained by unrelated datasets 
and independent investigators, our study underscores the 
fact that this is no substitute for the internal validation of 
data quality. Our assessment of EHR- derived billing data 
resulted in a screening rate that precisely matches that of 
the CDC using different methods; yet, this estimate was 
substantially incorrect. A study relying on a de- identified 
and unvalidatable claims database might have come to a 
similarly incorrect conclusion without any possibility of 
uncovering the truth.
Our work suggests the importance of caution when 
interpreting studies using data that cannot be subjected 
to internal checks of validity. The practice of data repur-
posing intrinsically represents a trade- off between feasi-
bility/statistical power and accuracy. Although we would 
not argue that accuracy is the be- all and end- all of clin-
ical research endeavours, research designs that propose 
to trade- off one for the other should ideally incorporate 
some semi- quantitative notion as to how accuracy is being 
sacrificed. Studies for which this cannot be done can be 
misleading and can bear adverse consequences for public 
health policy and impede efforts to improve healthcare 
quality.
Our study highlights at least one simple approach for 
confirming data quality—sampled record review. More 
complex approaches such as natural language processing 
and machine learning might eventually be able to 
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Table 3 Potential solutions to improve informatic classification and CRC screening
Reasons for true negative classification Potential solutions
Examinations ordered but not completed
  Colonoscopy ordered but not completed  ► More transparent documentation of referral status and outcome
 ► Clinic- based patient outreach
  Faecal immunochemical test ordered but not 
completed
 ► Clinic- based patient outreach
  CT colonography ordered but not completed  ► More transparent documentation of referral status and outcome
 ► Clinic- based patient outreach
Lack of documentation or incorrect documentation  ► Improved primary care education
 ► Improved gastroenterologist- primary care communication
Declined screening  ► Improved patient education
Insufficient time to discuss  ► Clinic- based strategies to encourage follow- up
Reasons for false- negative misclassification
Screening outside of UCSF  ► Patient- approved data sharing, harmonisation and interoperability
 ► Natural language processing
 ► Optical character recognition
 ► Deep learning
Screening prior to Epic EHR implementation  ► Institutional investment in clinical data integration and 
harmonisation
Database and query errors  ► Recruitment, training and funding for more clinical informaticians, 
especially clinician- investigators
 ► Institutional investment in clinical data integration and 
harmonisation
Misclassified as eligible for screening
Poor life expectancy, or risks outweighing benefits  ► Deep learning with natural language processing
Above risk (personal or family history of polyps)  ► Natural language processing
 ► Improved family history taking practices
 ► Patient consent for EHR data- sharing, chart- linkage by familial 
relationship
Not primary care empanelled  ► Deep learning with natural language processing
Reasons for false- positive misclassification
Ordered but incomplete faecal immunochemical test  ► EHR flag/reminders to repeat screening
Performed colonoscopy revealed inadequate bowel 
preparation
 ► Natural language processing
 ► EHR flag/reminders to repeat screening
EHR, electronic health records; UCSF, University of California, San Francisco.
perform this task using EHR data in a scalable way. We 
highlight some of these solutions in table 3 (see online 
supplementary methods table 2 for a definition of terms 
used in this manuscript, adapted with permission from 
Rudrapatna and Butte6). However, for the immediate 
future, we see manual review as being an integral part of 
any study relying on sources of routinely collected clinical 
data.
How do our results compare with previously published 
estimates? To our knowledge, only one study from Petrik 
et al14 has directly reported the accuracy of EHR billing 
codes in identifying screened and unscreened patients. 
They too reported a high positive predictive value, consis-
tent with our findings here. By contrast, they reported 
an 88% (85%–91%) negative predictive value, compared 
with 21% in our study.
We note several potential explanations. First, there 
were important differences in underlying cohorts: 
patients receiving preventative care within a safety- net 
system (eg, those under study by the Petrik et al) may be 
less likely to ‘shop around’ and receive fragmented care 
at different systems, unlike the patients at UCSF. Another 
potential explanation is that their study aimed to identify 
patients in need of screening, whereas this study aimed 
to accurately capture the prevalent screening rate. Our 
study excluded from the denominator any patient lacking 
a primary care relationship as well as those for whom 
the risks of screening outweigh the benefits. Unlike the 
study by Petrik et al, we did not informatically exclude 
patients with significant comorbid diagnoses or compute 
a Charlson Comorbidity Index; doing so would have 
introduced bias in our tertiary- care centre where many 
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sick patients undergo cancer screening prior to organ 
transplantation. We also did not treat referrals alone as 
positive evidence of screening; our protocol included the 
review of endoscopic reports to confirm the adequacy of 
the examination.
Common reasons for misclassification across both 
studies include note- based evidence of a qualifying 
screening examination. Half of the false- negative charts 
we reviewed had evidence of screening elsewhere, and a 
quarter of the charts had evidence of screening within our 
institution but generated by legacy EHR software prior to 
June 2012. Although 21% of the false negatives involved 
examinations performed within the expected scope of 
our database, some of these examinations occurred at the 
end of 2012 or in March 2018 (the month the database 
was queried), suggesting errors due to incomplete data 
migration. However, we also noted a variety of other idio-
syncratic errors inherent to the data itself. In our view, 
these errors are a common consequence of the complex 
processes involved in data capture and transformation. 
The identification and correction of insidious errors of 
this nature requires a significant degree of institutional 
investment in data engineering; it also requires the 
sustained involvement of many clinical experts optimally 
positioned to identify these errors early and provide 
corrective feedback (table 3).
The challenges inherent to obtaining accurate estimates 
from administrative healthcare data raise the important 
question: is the very enterprise of clinical informatics 
cost- effective (and is further investment justifiable)? 
Would research funds be better spent on improving the 
methods employed in the National Health Interview 
Survey (NHIS)? It is difficult to answer the first question 
in a rigorous way—how does one quantify or estimate 
the total future benefits of increasingly accessible health 
information? Nonetheless, our view is that the answer is 
clearly ‘yes’. EHR systems have already been paid for (at 
a sizeable cost) and widely implemented; reverting back 
to paper charts is not a viable option. In the setting of this 
existing ‘buy- in’, ongoing improvements to the capture 
and quality of healthcare data are inevitable because they 
underlie the capacity of health systems to continuously 
innovate in a competitive environment. Secondary use 
cases, such as research, will benefit as well. These sources 
of ‘real- world data’ serve as important confirmations of 
(or challenges to) the results of prospective studies such 
as the NHIS, and are broadly generalisable to virtually all 
domains in healthcare beyond CRC screening.
A key strength of this work lies in the study method-
ology. This study used a comprehensive list of diagnosis 
and procedure codes developed in close collaboration 
with proceduralists, billing staff and members of the 
quality improvement and accountable care division. 
Study investigators simultaneously contributed to both 
the query development and the chart review process, 
and improved both as a result. All charts independently 
examined by one internist and gastroenterologist each. 
We reported robust binomial CIs and tested the coverage 
probability of the corrected prevalence estimate with 
Monte- Carlo simulation. This work was able to identify, 
at a fairly granular level, reasons for errors at all levels, 
from clinical informatics to the provision of primary care. 
This audit led to the identification of several clinical care 
errors, with clinicians informed and education provided 
where appropriate.
We acknowledge several limitations. First, the chart 
review process was challenging. Interpreting clinical 
notes is inherently a subjective process, and we encoun-
tered many edge cases that required discussion, criteria 
refinement and imperfect resolution. The nuances of 
balancing of competing agenda, incorporating values 
and weighing risk- benefits within a time- limited clinic 
visit frequently do not make it to the written page. We 
also note other potential sources of measurement bias. 
We decided to accept note- based documentation as suffi-
cient evidence that screening was performed, rather than 
having required the full screening report in the chart. We 
also suspect that relevant family history (eg, interval diag-
noses of advanced polyps) are not regularly rechecked 
and updated at each visit, contributing to some mismea-
surement. Lastly, the specific CRC screening rates at our 
institution may not generalise to other primary care clinic 
populations.
Although billing data derived from the EHR and 
claims data from healthcare payors are similar, they 
are not identical. Claims data may capture healthcare 
utilisation across multiple sites. EHR structured data 
captures local patient data irrespective of insured status 
or changes to insurance carrier. The EHR also carries 
the potential to explore a richer dataset including test 
results and unstructured data in the form of clinical 
notes. Both systems are subject to breaks and disconti-
nuities as patients leave and enter (or re- enter), as well 
as the errors inherent to intrinsically complex, non- 
research grade data.
Our results indicate that the primary care apparatus at 
our institution is effective at performing CRC screening. 
Nevertheless, we see several potential areas of improve-
ment. Improved documentation of the CRC screening 
decision and the disposition of screening referrals, 
regular updating of family history and greater commu-
nication between gastroenterologists and internists will 
help all healthcare institutions improve their screening 
rates. They may also improve informatic ascertainment of 
screened status in combination with technologies such as 
natural language processing, optical character recogni-
tion and deep learning (table 3).
However, the greatest challenge to the future of clinical 
informatics lies in the problem of bias in observational 
data. Identifying and managing bias is fundamentally a 
task that requires humility, vigilance and the collaborative 
engagement of diverse stakeholders and domain experts 
who understand the provenance and meaning of the 
data. It requires that we stress test our data openly and 
often before drawing conclusions or taking action.
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